Krystal Biotech, Inc.
NasdaqGS:KRYS
$ 164.10
+ $0.32 (0.20%)
$ 164.10
+ $0.32 (0.20%)
End-of-day quote: 05/17/2024

Krystal Biotech financials at a glance

The revenue of Krystal Biotech is reported as 0.0507 billion Dollars in the fiscal year 2023. The earnings were -2.72 Dollars per share in 2023, which was 50.46 higher than 2022. And about -0.1006 billion Dollars are reported as free cash flow in the financials of Krystal Biotech 2023. No dividends were paid to the shareholders of the Krystal Biotech stock NasdaqGS:KRYS in the financial year 2023.

$50.70M
Revenue
$-2.72
Earnings Per Share
93.90%
Gross Margin %
$-6.15M
Free Cash Flow
Revenue
50.70
Earnings Per Share
-2.72
Gross Margin %
93.90
Free Cash Flow
-6.15

Financials

Year Year TTM 2023 2022 2021 2020 2019 2016
Rev. Revenue N/A $50.70M $0.00M $0.00M $0.00M $0.00M $0.00M
GM % Gross Margin % 97.39% 93.90% 0.00% 0.00% 0.00% 0.00% 0.00%
OM Operating Margin 0.00% -,191.77% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Earnings Per Share $-1.13 $-2.72 $-5.49 $-3.13 $-1.71 $-1.20 $-1.31
Div. Dividends N/A $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio % 0 -0.00% -0.00% -0.00% -0.00% -0.00% 0
Sha. Shares N/AM 28.29M 25.76M 25.21M 22.19M 17.36M 3.49M
OCF Operating Cash Flow N/A $-88.80M $0.00M $0.00M $-26.08M $0.00M $0.00M
FCF Free Cash Flow N/A $-6.15M $-,153.55M $-,116.27M $-40.93M $0.00M $0.00M
FCFS Free Cash Flow Per Share $-4.49 $-3.70 $-6.02 $-5.24 $-2.18 $-1.58 $0.00